Analysis of Progression-Free Survival (PFS) by Prior Chemotherapy Use and Updated Safety in RADIANT-3: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial of Everolimus in Patients with Advanced Low- or Intermediate-Grade Pancreatic Neuroendocrine Tumors (pNET)

Hobday, Timothy

Pommier, Rodney ; Van Cutsem, Eric ; Panneerselvam, Ashok ; Saletan, Stephen ; Winkler, Robert E ; Yao, James C

Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, 1103 Clinical Sciences, 3202 Clinical sciences